
Medigrow Formulations Private Limited
About Medigrow Formulations Private Limited
Data last updated:
Medigrow Formulations Private Limited is a private limited company based in Tiruchirappalli, Tamil Nadu, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24230TN2021PTC145236.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sharmila Kannaiyan and Balakrishnan Rajendran.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 67/33 D Irayanar Street Thendral Nagar K Nagar Post, Tiruchirappalli, Tamil Nadu, India – 620021.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.15 Lakh, a decline of 75% compared to the previous year. For the same year it recorded a net profit of ₹46,477 (net margin 4.2%) and EBITDA of ₹46,477 (EBITDA margin 4.2%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years.
Company details
Contact details
Medigrow Formulations Private Limited's registered office is in Tiruchirappalli, Tamil Nadu.
- Registered Address67/33 D Irayanar Street Thendral Nagar K Nagar Post, Tiruchirappalli, Tamil Nadu, India – 620021
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medigrow Formulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medigrow Formulations Private Limited, buy the company report.
Financials of Medigrow Formulations Private Limited
FY 2025 filings availableMedigrow Formulations Private Limited reported revenue of ₹11.15 Lakh (down 75% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 30% over three years, including a 75% fall in the latest year. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹46,477 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹46,477 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.2% | |||
| Net Profit Margin | 4.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Medigrow Formulations Private Limited, buy the company report.
Board of directors of Medigrow Formulations Private Limited
Medigrow Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharmila Kannaiyan | Director | 13 Sep 2023 | 3 Years 1 Months | Current |
| Balakrishnan Rajendran Also directs: Laksha Promoters Private Limited | Director | 11 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Medigrow Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Universal Lifecare Private Limited | ₹11.21 Lakh (FY 2025) | 40.0% | Surat, Gujarat, India | |||
| Daymeddy Pharma Private Limited | ₹11.2 Lakh (FY 2023) | 62.0% | Panchkula, Haryana, India | |||
| Medigrow Formulations Private Limitedthis company | ₹11.15 Lakh (FY 2025) | ₹46,477 | 4.2% | -75.0% | Tiruchirappalli, Tamil Nadu, India | |
| Asvp Pharma Health Industries Private Limited | ₹11.01 Lakh (FY 2025) | -23.0% | Parakunnam, Kerala, India |
To see the full peer comparison of Medigrow Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigrow Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigrow Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medigrow Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medigrow Formulations Private Limited has 4 board changes on record since 2023: 2 appointments and 2 cessations. The latest: Balakrishnan Prabhu ceased to be Director on 13 Sep 2023.
Frequently asked questions
Medigrow Formulations is an active private limited company based in Tiruchirappalli, Tamil Nadu, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 August 2021 (5+ years old) and is registered under CIN U24230TN2021PTC145236.
Medigrow Formulations has 2 current directors:
- Sharmila Kannaiyan - Director
- Balakrishnan Rajendran - Director
The latest financial statements of Medigrow Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Medigrow Formulations is U24230TN2021PTC145236. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigrow Formulations was incorporated on 03 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Medigrow Formulations by revenue are Universal Lifecare Private Limited, Daymeddy Pharma Private Limited, Asvp Pharma Health Industries Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Balakrishnan Prabhu ceased to be Director on 13 Sep 2023. Sharmila Kannaiyan was appointed as Director on 13 Sep 2023. Balakrishnan Rajendran was appointed as Director on 11 Jul 2023. Medigrow Formulations has 4 board changes on record in total.
The registered office of Medigrow Formulations is at 6733 D Irayanar Street Thendral Nagar K Nagar Post, Tiruchirappalli, Tamil Nadu, India – 620021.
Medigrow Formulations operates in the chemicals industry, in the manufacturing segment.
Medigrow Formulations can be reached at its registered office: 6733 D Irayanar Street Thendral Nagar K Nagar Post, Tiruchirappalli, Tamil Nadu, India – 620021.
Medigrow Formulations is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.

